Diagnosis of Multi-drug Resistant Tuberculosis Mutations Using Hain Line Probe Assay and GeneXpert: A Study Done in Zimbabwe

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2015, Vol 5, Issue 8

Abstract

Background and Aims: Tuberculosis (TB) is a global public health problem and one of the leading causes of death. Worldwide, 31% of all estimated new TB cases are from Africa. Zimbabwe is one of the 22 high TB burden countries. Multi-drug resistant TB (MDR-TB) poses challenges in TB control, hence the need for rapid laboratory diagnosis of MDR-TB for optimal treatment and reducing spread. The study aim was to investigate genetic mutations associated with MDR-TB isolates from various Harare clinics using the GeneXpert MTB/RIF® by Cepheid and Genotype MTBDRplus, to improve the diagnosis and management of MDR-TB. Methods: Samples from adults aged 16 years and older, recruited from several polyclinics in the southern suburbs of Harare were used for our study. All laboratory tests prior to this study had been carried out at Biomedical research and training institute’s level three bio-safety TB laboratory from January 2008-August 2012. Ethical approval was sought from BRTI Institutional review board. A total of 69 (37 MDR-TB and 32 non MDR-TB) archived isolates processed on Genotype MTBDRplus (Hains) and corresponding 39 sputum were processed on the GeneXpert. Mutations on rpoB, katG and inhA genes were observed. The gold standard was culture. Diagnostic accuracy of both methods and their level of agreement were calculated. Results: Of the 37/69 isolates screened by culture for MDR-TB, 88.4% were confirmed by MTBDR® plus line probe assay (Hains). Within the 39 isolates tested using the Xpert MTB/RIF (GeneXpert) assay 12 were true MDR-TB. Over 8 single nucleotide polymorphisms were observed on the three genes conferring Rifampicin and Isoniazide drug resistance. The Hains and GeneXpert had an almost perfect agreement with a kappa value of 0.82. Conclusion: Genetic markers can be used in the diagnosis of MDR-TB, to complement phenotypic methods such as culture. Using the commercial methods, Hains and GeneXpert, 88.4-94.2% of drug resistance maybe detected. Furthermore, we recommend sequencing so as to identify novel mutations and to design a kit that is custom made for the population.

Authors and Affiliations

S. Dube-Mandishora Racheal, Dhlamini Zephaniah, Mutetwa Reggie, Duri Kerina, Stray-Pedersen Babill, Mason Peter

Keywords

Related Articles

Nutritional Assessment of Children Aged Twelve to Fifty Nine Months with Diarrhoea, Using Mid-upper-arm Circumference (MUAC)

Background: Protein energy malnutrition is a significant cause of morbidity and mortality in children between the ages of 12 and 59 months and diarrhoea has been shown to have a bi-directional relationship with malnutrit...

Clinical Features and Outcomes of Mycophenolate Mofetil-induced Diarrhea: A Systematic Review

Mycophenolate Mofetil (MMF) is an immunosuppressive drug frequently used for prevention of graft rejection in solid-organ and hematopoietic stem cell transplants. MMF-induced diarrhea is a known complication, however, de...

Effect of Nurse-led Training on Self-management of Diabetes among Diabetic Patients Attending Medical Outpatient Clinic in General Hospital Odan,

Aims: Diabetes mellitus is a common metabolic disease associated with poor quality of life and great financial burden. Despite training on self-management of diabetes mellitus, its knowledge and practice among diabetic p...

Influence of Hepatitis B and Hepatitis C Virus Infections and Human Immunodeficiency Virus Therapy on Liver Status of Patients with Human Immunodeficiency Virus

Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are emerging among Human Immunodeficiency Virus (HIV) patients. Aim: To determine the impact of the presence of hepatitis B and hepatitis C viral infection...

A Simple System to Predict Mortality in Medical Intensive Care Unit

Background: Advances in critical care have increased survival chances and the demand for a scientific approach to outcome prediction. The present study aimed to investigate the associations of clinical information, demog...

Download PDF file
  • EP ID EP347098
  • DOI 10.9734/BJMMR/2015/13979
  • Views 60
  • Downloads 0

How To Cite

S. Dube-Mandishora Racheal, Dhlamini Zephaniah, Mutetwa Reggie, Duri Kerina, Stray-Pedersen Babill, Mason Peter (2015). Diagnosis of Multi-drug Resistant Tuberculosis Mutations Using Hain Line Probe Assay and GeneXpert: A Study Done in Zimbabwe. Journal of Advances in Medicine and Medical Research, 5(8), 1044-1052. https://europub.co.uk/articles/-A-347098